Stratos Wealth Partners’s Vivani Medical VANI Stock Holding History

Stratos Wealth Partners’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,114	Closed	-$31K	–	1231
2022 Q2	$31K	Hold	5,114	–	–	﹤0.01%	1172
2022 Q1	$22K	Sell	5,114 -67	-1%	-$282	﹤0.01%	1256
2021 Q4	$25K	Hold	5,181	–	–	﹤0.01%	1244
2021 Q3	$50K	Hold	5,181	–	–	﹤0.01%	1165
2021 Q2	$77K	Sell	5,181 -12	-0.2%	-$232	﹤0.01%	1164
2021 Q1	$129K	Buy	+5,193	New	+$77.5K	﹤0.01%	1077
2018 Q4	–	Sell	-215	Closed	-$10K	–	2430
2018 Q3	$10K	Buy	+215	New	+$8.68K	﹤0.01%	2203
2018 Q2	–	Sell	-242	Closed	-$11K	–	2514
2018 Q1	$11K	Hold	242	–	–	﹤0.01%	2289
2017 Q4	$11K	Buy	+242	New	+$8.04K	﹤0.01%	2135

Other funds holding VANI

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $835M AUM 22.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return

Stratos Wealth Partners's VANI Position: Q3 2022 in Review

Stratos Wealth Partners sold out of Vivani Medical (VANI) in Q3 2022, closing a stake of 5,114 shares — an estimated $31K sold.

Stratos Wealth Partners first reported a position in VANI in Q4 2017 and held it in 9 quarters. The position peaked at $129K in Q1 2021. 28 funds tracked by Wall St. Rank hold VANI as of Q3 2022.

Stratos Wealth Partners reported no remaining Vivani Medical position as of Q3 2022 after selling out during the quarter.
Stratos Wealth Partners sold 5,114 Vivani Medical shares in Q3 2022, an estimated $31K.
Stratos Wealth Partners first reported a position in Vivani Medical in Q4 2017 and held it in 9 quarters.
Stratos Wealth Partners's Vivani Medical position peaked at $129K in Q1 2021.
28 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2022.

Based on Stratos Wealth Partners's 13F filing for Q3 2022, filed 24 Oct 2022.